MDNYSEServices-HospitalsFiscal year ends December 31
Pediatrix Medical Group, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$27.30−0.08 (-0.29%)
Close on Oct 19, 2026
- Market cap
- $2.22B
- P/E (TTM)
- 13.1
- Dividend yield
- –
Pediatrix Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Hospitals companies for comparison
Valuation
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| Market Cap | $2.22B | $1.14B |
| Enterprise Value | $2.40B | $1.35B |
| PE Ratio | 13.06 | 22.72 |
| PS Ratio | 1.14 | 1.63 |
| PB Ratio | 2.52 | 3.03 |
| P/OCF Ratio | 8.99 | 15.44 |
Enterprise value
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| EV / Sales | 1.23 | 1.78 |
| EV / EBITDA | 10.06 | 14.40 |
| EV / EBIT | 11.13 | 19.04 |
Income (trailing twelve months)
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| Revenue | $1.95B | $561.90M |
| Operating Income | $215.42M | -$1.81M |
| Pretax Income | $226.22M | -$572.42K |
| Net Income | $174.81M | -$1.16M |
| EBITDA | $238.51M | -$20.72K |
| EPS (Diluted) | $2.09 | -$0.02 |
Margins
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| Operating Margin | 11.0% | -4.45% |
| Pretax Margin | 11.6% | 1.54% |
| Profit Margin | 8.96% | -2.91% |
| EBITDA Margin | 12.2% | 2.41% |
Returns
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| Return on Equity (ROE) | 20.4% | 1.84% |
| Return on Assets (ROA) | 8.26% | -3.06% |
| Return on Invested Capital (ROIC) | 15.5% | 2.11% |
| Return on Capital Employed (ROCE) | 13.2% | -0.57% |
Growth
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 0.51% | 6.92% |
| Net Income Growth (YoY) | 59.0% | 19.6% |
| EPS Growth (YoY) | 62.0% | 25.8% |
| Revenue Growth (3Y CAGR) | -0.99% | 10.9% |
| Revenue Growth (5Y CAGR) | 1.99% | 13.2% |
| EPS Growth (3Y CAGR) | 34.9% | 19.8% |
Balance sheet
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $404.20M | $48.71M |
| Total Debt | $584.24M | $140.00M |
| Net Cash (Debt) | -$180.05M | $205.49K |
| Net Cash Per Share | -$2.22 | $0.01 |
| Equity (Book Value) | $880.98M | $235.16M |
| Book Value Per Share | $10.84 | $3.48 |
| Tangible Book Value | -$401.79M | $703.69K |
| Working Capital | $158.56M | $30.48M |
Financial position
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| Current Ratio | 1.32 | 1.40 |
| Quick Ratio | 1.26 | 1.02 |
| Debt / Equity | 0.66 | 0.66 |
| Debt / EBITDA | 2.45 | 2.61 |
| Net Debt / EBITDA | 0.75 | 2.15 |
| Interest Coverage | 6.31 | -0.63 |
Cash flow (trailing twelve months)
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| Operating Cash Flow | $246.86M | $3.10M |
Efficiency
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| Asset Turnover | 0.92 | 0.87 |
Dividends and yields
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| Earnings Yield | 7.88% | -1.25% |
| Buyback Yield | 6.59% | 0.32% |
| Shareholder Yield | 6.59% | 0.65% |
Shares
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| Shares Outstanding | 81,253,300 | 58,282,400 |
| Shares Change (YoY) | -1.18% | 2.68% |
| Shares Change (QoQ) | -1.02% | 0.32% |
| Float | 80,085,500 | 33,780,100 |
| Shares Held by Insiders | 1.44% | 16.4% |
| Shares Held by Institutions | 103.0% | 85.9% |
Taxes
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| Income Tax | $51.41M | $697.00K |
| Effective Tax Rate | 22.7% | 23.1% |
Scores
| Measure | Pediatrix Medical | Industry median |
|---|---|---|
| Graham Number | $22.58 | $19.59 |
| Graham Upside | -17.3% | -47.5% |
| Altman Z-Score | 2.39 | 1.96 |
| Piotroski F-Score | 6 | 5 |
Calculated by StockData from Pediatrix Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.